Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Case Reports in Obstetrics and Gynecology|May 12, 2018
A Potentially Useful Addition to Predict Spontaneous Resolution of Uterine Artery Pseudoaneurysm: Absence of Diastolic FlowYosuke Baba, Hironori Takahashi, Hiroyuki Morisawa, et al.
Surgical Technology International|June 10, 2015
Laparoscopic Cholecystectomy for a Patient with Left-sided GallbladderTsutomu Namikawa, Kohei Tamura, Masao Morita, et al.
Pharmaceutics|February 27, 2026
Combined Intraperitoneal and Systemic Chemotherapy for Peritoneal Metastases: Drug Delivery Concepts, Pharmacokinetics, and Clinical Applications: A Narrative ReviewKohei Tamura, Joji Kitayama, Yasushi Saga, et al.
Gynecologic Oncology Reports|February 27, 2026
Acute myocardial infarction caused by coronary tumor embolism from uterine leiomyosarcoma: a case reportYumi Shirasu, Kohei Tamura, Miki Shinohara, et al.
Cureus|February 20, 2026
Progesterone Enhances the Sensitivity of Ovarian Cancer Cells to Poly (ADP-Ribose) Polymerase (PARP) Inhibitors by Suggesting a Role for Transcription-Replication Conflict-Related Pathways: An In Vitro StudyEri Suizu, Takahiro Koyanagi, Yasushi Saga, et al.
Advances in Colloid and Interface Science|February 12, 2026
Advances in shale gas development: Resource assessment, production mechanisms, and CO<sub>2</sub> sequestration potentialWuquan Li, Yunfeng Liang, Jinrong Cao, et al.
Cancer Reports (Hoboken, N.J.)|December 22, 2024
Forced Vasohibin-1 Expression Increases Paclitaxel Sensitivity of Ovarian Cancer by Inhibiting Microtubule ActivityTakahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi, et al.
The Journal of Obstetrics and Gynaecology Research|November 4, 2020
Efficacy and toxicity of pegylated liposomal doxorubicin as therapy for recurrent ovarian cancer in relation to the number of previous chemotherapy regimens: Comparison with gemcitabineYoshifumi Takahashi, Yuji Takei, Shizuo Machida, et al.
Experimental and Therapeutic Medicine|May 27, 2022
Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case reportShuntaro Umihira, Takahiro Koyanagi, Kohei Tamura, et al.
Cancer Reports (Hoboken, N.J.)|April 24, 2025
Progesterone Enhances Sensitivity of Ovarian Cancer Cells to SN38 Through Inhibition of Topoisomerase I and Inducing FerroptosisTakahiro Koyanagi, Yasushi Saga, Yoshifumi Takahashi, et al.
Pageof 5